Junqing Han
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Metabolomics and Mass Spectrometry Studies
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Oncology 11
- Lung Cancer Research Studies 4
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Ling Zhang (1 shared paper)Bo Zhang (1 shared paper)Zhixue Wang (1 shared paper)Fanghua Qi (1 shared paper)Lin Zhao (1 shared paper)Anyuan Li (1 shared paper)Weibo Wang (2 shared papers)Rong Shen (2 shared papers)
- Journals
- Tumor Biology (4 papers)Journal of Materials Research and Technology (2 papers)Cellular Reprogramming (1 paper)Food Bioscience (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Junqing Han
36 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 494
- Molecular Biology 683
- Pharmacology 81
- Oncology 238
- Complementary and alternative medicine 71
Countries citing papers authored by Junqing Han
This map shows the geographic impact of Junqing Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Han more than expected).
Fields of papers citing papers by Junqing Han
This network shows the impact of papers produced by Junqing Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Han. The network helps show where Junqing Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Junqing Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer Hit paper breakdown → | 2015 | 359 |
| 2 | 2017 | 158 | |
| 3 | MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. | 2015 | 83 |
| 4 | 2016 | 67 | |
| 5 | 2014 | 65 | |
| 6 | 2015 | 57 | |
| 7 | 2011 | 56 | |
| 8 | 2016 | 44 | |
| 9 | 2019 | 39 | |
| 10 | 2020 | 28 | |
| 11 | 2013 | 26 | |
| 12 | 2016 | 26 | |
| 13 | 2017 | 24 | |
| 14 | 2014 | 19 | |
| 15 | 2022 | 17 | |
| 16 | XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects. | 2015 | 17 |
| 17 | 2014 | 16 | |
| 18 | 2015 | 14 | |
| 19 | 2015 | 11 | |
| 20 | 2017 | 10 |
About Junqing Han
Junqing Han is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (4 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Circular RNAs in diseases (3 papers), Aluminum Alloys Composites Properties (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (494 citations), Molecular Biology (683 citations), Pharmacology (81 citations), Oncology (238 citations) and Complementary and alternative medicine (71 citations). Junqing Han has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Ling Zhang, Bo Zhang, Zhixue Wang, Fanghua Qi, Lin Zhao, Anyuan Li, Weibo Wang, Rong Shen, Chuanxi Wang and Shuai Wang. Their work appears in journals such as Tumor Biology, Journal of Materials Research and Technology, Cellular Reprogramming, Food Bioscience and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.